OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
Vasiliki Stravokefalou, Dimitris Stellas, Sevasti Karaliota, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Vasiliki Stravokefalou, Dimitris Stellas, Sevasti Karaliota, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Showing 14 citing articles:
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Research progress of interleukin-15 in cancer immunotherapy
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
The role of myokines in cancer: crosstalk between skeletal muscle and tumor
Se-Young Park, Byeong-Oh Hwang, Na‐Young Song
BMB Reports (2023) Vol. 56, Iss. 7, pp. 365-373
Open Access | Times Cited: 19
Se-Young Park, Byeong-Oh Hwang, Na‐Young Song
BMB Reports (2023) Vol. 56, Iss. 7, pp. 365-373
Open Access | Times Cited: 19
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom S. Leidner, Kevin C. Conlon, Douglas G. McNeel, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007725-e007725
Open Access | Times Cited: 11
Rom S. Leidner, Kevin C. Conlon, Douglas G. McNeel, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007725-e007725
Open Access | Times Cited: 11
Radiotherapy has a survival advantage over surgery in patients with choroidal melanoma: a retrospective cohort study of 6,871 patients
Yifan Wu, Lu Shi, Zhiqiang Ye, et al.
Frontiers in Surgery (2025) Vol. 12
Open Access
Yifan Wu, Lu Shi, Zhiqiang Ye, et al.
Frontiers in Surgery (2025) Vol. 12
Open Access
Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
Dimitris Stellas, Sevasti Karaliota, Vasiliki Stravokefalou, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112501-112501
Open Access | Times Cited: 5
Dimitris Stellas, Sevasti Karaliota, Vasiliki Stravokefalou, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112501-112501
Open Access | Times Cited: 5
Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients
Kohei Takei, Toshiki Kijima, Naoya Ookubo, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5591-5591
Open Access | Times Cited: 4
Kohei Takei, Toshiki Kijima, Naoya Ookubo, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5591-5591
Open Access | Times Cited: 4
Research History, Current Trends, and Future Prospects of Liquid Biopsy in Triple-Negative Breast Cancer: An Analysis from a Global Perspective
Yi Qu, Jixian Wan, Ruihan Li, et al.
Research Square (Research Square) (2024)
Open Access
Yi Qu, Jixian Wan, Ruihan Li, et al.
Research Square (Research Square) (2024)
Open Access
Mechanisms Underlying the Rarity of Skeletal Muscle Cancers
David S. Kump
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6480-6480
Open Access
David S. Kump
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6480-6480
Open Access
Interleukin signaling in the regulation of natural killer cells biology in breast cancer
Jiachi Xu, Hongyu Gao, Muhammad Salman Azhar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jiachi Xu, Hongyu Gao, Muhammad Salman Azhar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
John A. Hangasky, Rodrigo Fernández, Dimitris Stellas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
John A. Hangasky, Rodrigo Fernández, Dimitris Stellas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cellular senescence and tumor dormancy at the crossroads of therapy resistance, metastasis and cancer stemness
Qurrat Ul Ain
Asia-Pacific Journal of Oncology (2024)
Open Access
Qurrat Ul Ain
Asia-Pacific Journal of Oncology (2024)
Open Access
Circulating tumor cells and host immunity: A tricky liaison
Elena Muraro, Giulia Brisotto
International review of cell and molecular biology (2023), pp. 131-157
Closed Access
Elena Muraro, Giulia Brisotto
International review of cell and molecular biology (2023), pp. 131-157
Closed Access
